Compare · MD vs PACS
MD vs PACS
Side-by-side comparison of Pediatrix Medical Group Inc. (MD) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MD and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- PACS is the larger of the two at $6.96B, about 3.2x MD ($2.19B).
- MD has been more active in the news (13 items in the past 4 weeks vs 7 for PACS).
- MD has more recent analyst coverage (10 ratings vs 6 for PACS).
- Company
- Pediatrix Medical Group Inc.
- PACS Group Inc.
- Price
- $27.05+1.67%
- $43.93-0.68%
- Market cap
- $2.19B
- $6.96B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 13
- 7
- Recent ratings
- 10
- 6
Pediatrix Medical Group Inc.
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Latest MD
- Pediatrix Medical Group downgraded by Jefferies with a new price target
- Director Young Sylvia Jean returned $492,470 worth of shares to the company (18,500 units at $26.62), decreasing direct ownership by 38% to 29,786 units (SEC Form 4)
- Director Sansone Guy P was granted 472 shares, increasing direct ownership by 0.54% to 87,416 units (SEC Form 4)
- Director Starcher John M. Jr. was granted 472 shares, increasing direct ownership by 0.64% to 73,732 units (SEC Form 4)
- Director Young Sylvia Jean was granted 472 shares, increasing direct ownership by 0.99% to 48,286 units (SEC Form 4)
- Director Rucker Michael A. was granted 472 shares, increasing direct ownership by 0.71% to 66,769 units (SEC Form 4)
- Director Newman Kurt Douglas was granted 472 shares, increasing direct ownership by 3% to 17,405 units (SEC Form 4)
- Director Linynsky Laura A was granted 472 shares, increasing direct ownership by 1% to 39,900 units (SEC Form 4)
- Director Weis Shirley A was granted 472 shares, increasing direct ownership by 3% to 19,095 units (SEC Form 4)
- Director Mceachin Thomas was granted 472 shares, increasing direct ownership by 7% to 7,668 units (SEC Form 4)
Latest PACS
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $6,611,433 worth of shares (150,550 units at $43.92) as part of a pre-agreed trading plan, decreasing direct ownership by 0.27% to 54,694,866 units (SEC Form 4)
- Co-Founder, CEO & Chairman Murray Jason Hulse sold $10,437,434 worth of shares (236,116 units at $44.20) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 54,845,416 units (SEC Form 4)
- President & COO Jergensen Joshua sold $1,823,689 worth of shares (40,000 units at $45.59) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,536,320 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by PACS Group Inc.
- PACS Group, Inc. Reports Second Quarter 2026 Results
- PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by PACS Group Inc.
- PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Call
- President & COO Jergensen Joshua sold $1,800,718 worth of shares (40,000 units at $45.02) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 2,576,320 units (SEC Form 4)
- Director Hancock Mark sold $613,795 worth of shares (13,628 units at $45.04) as part of a pre-agreed trading plan, decreasing direct ownership by 0.03% to 53,906,884 units (SEC Form 4)